Bill Text — Sep 16, 2012
This bill’s text is now available.
GovTrack Insider, our Kickstarter-backed work to summarize bills in Congress, has resumed. Here’s what we’ve been up to:
Sep 29, 2010
111th Congress, 2009–2010
This bill was introduced on September 29, 2010, in a previous session of Congress, but was not enacted.
Senator from Vermont
Read Text »
Last Updated: Sep 29, 2010
Length: 10 pages
A bill to ensure that rules for the approval of pharmaceutical and biological products do not require violations of medical ethics in the testing of products in humans and vertebrate animals.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 3506 (112th).
This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 3921”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 3921 — 111th Congress: Ethical Pathway Act of 2010. Retrieved from https://www.govtrack.us/congress/bills/111/s3921
“S. 3921 — 111th Congress: Ethical Pathway Act of 2010.” www.GovTrack.us. 2010. February 5, 2016 <https://www.govtrack.us/congress/bills/111/s3921>
|title=S. 3921 (111th)
|accessdate=February 5, 2016
|author=111th Congress (2010)
|date=September 29, 2010
|quote=Ethical Pathway Act of 2010